1. |
Jortveit J, Pripp AH, Langørgen J, et al. Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction. Eur J Prev Cardiol, 2019, 26(13): 1373-1382.
|
2. |
Feistritzer HJ, Desch S, Zeymer U, et al. Prognostic impact of atrial fibrillation in acute myocardial infarction and cardiogenic shock. Circ Cardiovasc Interv, 2019, 12(6): e007661.
|
3. |
Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace, 2018, 20(2): 263-270.
|
4. |
Ruddox V, Sandven I, Munkhaugen J, et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol, 2017, 24(14): 1555-1566.
|
5. |
Xu Y, Ouyang X, Yan L, et al. Sin1 (stress-activated protein kinase-interacting protein) regulates ischemia-induced microthrombosis through integrin αⅡbβ3-mediated outside-in signaling and hypoxia responses in platelets. Arterioscler Thromb Vasc Biol, 2018, 38(12): 2793-2805.
|
6. |
Ezekowitz MD, Eikelboom J, Oldgren J, et al. Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation. Europace, 2016, 18(7): 973-978.
|
7. |
Hijazi Z, Hohnloser SH, Oldgren J, et al. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis. Am Heart J, 2018, 198: 169-177.
|
8. |
van Rein N, Heide-Jørgensen U, Lijfering WM, et al. Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy. Circulation, 2019, 139(6): 775-786.
|
9. |
Haller PM, Sulzgruber P, Kaufmann C, et al. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother, 2019, 5(4): 226-236.
|
10. |
Lopes RD, Rao M, Simon DN, et al. Triple vs dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. Am J Med, 2016, 129(6): 592-599.
|
11. |
Cao Y, Tian XY, Zhang R, et al. Short- and long-term efficacy and safety of triple vs. dual antithrombotic therapy in patients with drug-eluting stent implantation and an indication for oral anticoagulation: A meta-analysis. Int J Clin Pharmacol Ther, 2016, 54(12): 950-965.
|
12. |
Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke, 2007, 38(2 Suppl): 624-630.
|
13. |
Bedeir K, Holmes DR, Cox JL, et al. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation. J Thorac Cardiovasc Surg, 2017, 153(5): 1097-1105.
|
14. |
Caliskan E, Sahin A, Yilmaz M, et al. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery. Europace, 2018, 20(7): e105-e114.1.
|
15. |
Emmert MY, Puippe G, Baumüller S, et al. Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg, 2014, 45(1): 126-131.
|
16. |
Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: Ⅰ. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-Ⅲ] study). J Am Soc Echocardiogr, 1999, 12(12): 1080-1087.
|
17. |
Ono K, Iwama M, Kawasaki M, et al. Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation. Cardiovasc Ultrasound, 2012, 27(10): 50.
|
18. |
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons. Circulation, 2019, 140(2): e125-e151.
|
19. |
黄从新, 张澍, 黄德嘉, 等. 左心耳干预预防心房颤动患者血栓栓塞事件: 目前的认识和建议-2019. 中国心脏起搏与心电生理杂志, 2019, 33(5): 385-401.
|
20. |
Squiers JJ, Edgerton JR. Surgical closure of the left atrial appendage: the past, the present, the future. J Atr Fibrillation, 2018, 10(5): 1642.
|